DR_SEQAN:: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes

被引:11
|
作者
Garriga, C [1 ]
Menéndez-Arias, L [1 ]
机构
[1] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
关键词
D O I
10.1186/1471-2334-6-44
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Genotypic assays based on DNA sequencing of part or the whole reverse transcriptase (RT)- and protease (PR)-coding regions of the human immunodeficiency virus type 1 (HIV-1) genome have become part of the routine clinical management of HIV-infected individuals. However, the results are difficult to interpret due to complex interactions between mutations found in viral genes. Results: DR_SEQAN is a tool to analyze RT and PR sequences. The program output includes a list containing all of the amino acid changes found in the query sequence in comparison with the sequence of a wild-type HIV-1 strain. Translation of codons containing nucleotide mixtures can result in potential ambiguities or heterogeneities in the amino acid sequence. The program identifies all possible combinations of 2 or 3 amino acids that derive from translation of triplets containing nucleotide mixtures. In addition, when ambiguities affect codons relevant for drug resistance, DR_SEQAN allows the user to select the appropriate mutation to be considered by the program's drug resistance interpretation algorithm. Resistance is predicted using a rule-based algorithm, whose efficiency and accuracy has been tested with a large set of drug susceptibility data. Drug resistance predictions given by DR_SEQAN were consistent with phenotypic data and coherent with predictions provided by other publicly available algorithms. In addition, the program output provides two tables showing published drug susceptibility data and references for mutations and combinations of mutations found in the analyzed sequence. These data are retrieved from an integrated relational database, implemented in Microsoft Access, which includes two sets of non-redundant core tables (one for combinations of mutations in the PR and the other for combinations in the RT). Conclusion: DR_SEQAN is an easy to use off-line application that provides expert advice on HIV genotypic resistance interpretation. It is coded in Visual Basic for use in PC/Windows-based platforms. The program is freely available under the General Public License. The program (including the integrated database), documentation and a sample sequence can be downloaded from http://www2.cbm.uam.es:8080/Imenendez/DR_SEQAN.zip
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Mechanistic insights into the suppression of drug resistance by human immunodeficiency virus type 1 reverse transcriptase using α-boranophosphate nucleoside analogs
    Deval, J
    Alvarez, K
    Selmi, B
    Bermond, M
    Boretto, J
    Guerreiro, C
    Mulard, L
    Canard, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) : 3838 - 3846
  • [22] Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance
    Galli, RA
    Sattha, B
    Wynhoven, B
    O'Shaughnessy, MV
    Harrigan, PR
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) : 2900 - 2907
  • [23] ZIDOVUDINE TREATMENT RESULTS IN THE SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WHOSE GENOTYPES CONFER INCREASING LEVELS OF DRUG-RESISTANCE
    KELLAM, P
    BOUCHER, CAB
    TIJNAGEL, JMGH
    LARDER, BA
    JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 341 - 351
  • [24] Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai
    Zhong, Ping
    Pan, Qichao
    Ning, Zhen
    Xue, Yile
    Gong, Juli
    Zhen, Xiaohong
    Zhou, Leming
    Sheng, Fangwei
    Zhang, Wei
    Gai, Jing
    Cheng, Hua
    Yue, Qing
    Xing, Hui
    Zhuang, Minghua
    Lu, Wei
    Shao, Yiming
    Kang, Laiyi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (07) : 847 - 856
  • [25] Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba
    Aleman, Yoan
    Vinken, Lore
    Kour, Vivian
    Perez, Lissette
    Alvarez, Alina
    Abrahantes, Yeissel
    Fonseca, Carlos
    Perez, Jorge
    Correa, Consuelo
    Soto, Yudira
    Schrooten, Yoeri
    Vandamme, Anne-Mieke
    Van Laethem, Kristel
    PLOS ONE, 2015, 10 (02):
  • [26] Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004-2021
    Aung, Su
    Novitsky, Vlad
    Steingrimsson, Jon
    Gillani, Fizza S.
    Howison, Mark
    Nagel, Katherine
    Solomon, Matthew
    Bertrand, Thomas
    Bhattarai, Lila
    Fulton, John
    Bandy, Utpala
    Kantor, Rami
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [27] Simultaneous and sensitive detection of human immunodeficiency virus type 1 (HIV) drug resistant genotypes by multiplex oligonucleotide ligation assay
    Ellis, Giovanina M.
    Vlaskin, Tatyana A.
    Koth, Andrew
    Vaz, Louise E.
    Dross, Sandra E.
    Beck, Ingrid A.
    Frenkel, Lisa M.
    JOURNAL OF VIROLOGICAL METHODS, 2013, 192 (1-2) : 39 - 43
  • [28] Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for Antiretroviral therapy
    Ambrose, Zandrea
    Palmer, Sarah
    Boltz, Valerie F.
    Kearney, Mary
    Larsen, Kay
    Polacino, Patricia
    Flanary, Leon
    Oswald, Kelli
    Piatak, Michael, Jr.
    Smedley, Jerem
    Shao, Wei
    Bischofberger, Norbert
    Maldarelli, Frank
    Kimata, Jason T.
    Mellors, John W.
    Hu, Shiu-Lok
    Coffin, John M.
    Lifson, Jeffrey D.
    KewalRamani, Vineet N.
    JOURNAL OF VIROLOGY, 2007, 81 (22) : 12145 - 12155
  • [29] Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan
    Fujisaki, Seiichiro
    Fujisaki, Saeko
    Ibe, Shiro
    Asagi, Tsukasa
    Itoh, Toshihiro
    Yoshida, Shigeru
    Koike, Takao
    Oie, Masayasu
    Kondo, Makiko
    Sadamasu, Kenji
    Nagashima, Mami
    Gatanaga, Hiroyuki
    Matsuda, Masakazu
    Ueda, Mikio
    Masakane, Aki
    Hata, Mami
    Mizogami, Yasushi
    Mori, Haruyo
    Minami, Rumi
    Okada, Kiyomi
    Watanabe, Kanako
    Shirasaka, Takuma
    Oka, Shinichi
    Sugiura, Wataru
    Kaneda, Tsuguhiro
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2007, 60 (2-3) : 113 - 117
  • [30] Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: Virus fitness in the absence and in the presence of drug
    Mammano, F
    Trouplin, V
    Zennou, V
    Clavel, F
    JOURNAL OF VIROLOGY, 2000, 74 (18) : 8524 - 8531